137 related articles for article (PubMed ID: 7956716)
21. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
Arboleya L; Sánchez J; Iglesias G; Arranz JL
Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
[TBL] [Abstract][Full Text] [Related]
22. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
23. Paget's disease of bone: five regimens of pamidronate treatment.
Pepersack T; Karmali R; Gillet C; François D; Fuss M
Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
Mautalen CA; Gonzalez D; Ghiringhelli G
Bone; 1985; 6(6):429-32. PubMed ID: 4096879
[TBL] [Abstract][Full Text] [Related]
25. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
Drake S; Massie JD; Postlethwaite AE; Palmieri GM
Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
[TBL] [Abstract][Full Text] [Related]
26. Tubular excretion of phosphate in Paget's disease of bone. Effect of pamidronate.
Constantin A; Laroche M; Moulinier L; Bon E; Ramonjisoa M; Cantagrel A; Mazieres B
Rev Rhum Engl Ed; 1995; 62(7-8):493-500. PubMed ID: 8574612
[TBL] [Abstract][Full Text] [Related]
27. Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.
Fenton AJ; Gutteridge DH; Kent GN; Price RI; Retallack RW; Bhagat CI; Worth GK; Thompson RI; Watson IG; Barry-Walsh C
Clin Endocrinol (Oxf); 1991 Mar; 34(3):197-204. PubMed ID: 2036728
[TBL] [Abstract][Full Text] [Related]
28. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
29. Pamidronate infusions for the treatment of Paget's disease of bone.
Mazieres B; Ahmed I; Moulinier L; Bon E; Cantagrel A; Laroche M
Rev Rhum Engl Ed; 1996 Jan; 63(1):36-43. PubMed ID: 9064108
[TBL] [Abstract][Full Text] [Related]
30. [Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
Scharla SH; Grauer A; Ziegler R
Klin Wochenschr; 1991 Jan; 69(1):25-30. PubMed ID: 2016845
[TBL] [Abstract][Full Text] [Related]
31. Effects of intravenous pamidronate therapy on Paget's disease of bone.
Bombassei GJ; Yocono M; Raisz LG
Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
[TBL] [Abstract][Full Text] [Related]
32. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC
Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
[TBL] [Abstract][Full Text] [Related]
33. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
Papapoulos SE; Frolich M; Mudde AH; Harinck HI; vd Berg H; Bijvoet OL
J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
[TBL] [Abstract][Full Text] [Related]
34. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
35. Paget's disease of bone: presentation, extent and response to bisphosphonates.
Wang LM; Au-Yeong ML; McKenna MJ
Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonate resistance in Paget's disease of bone.
Joshua F; Epstein M; Major G
Arthritis Rheum; 2003 Aug; 48(8):2321-3. PubMed ID: 12905487
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).
Ryan PJ; Sherry M; Gibson T; Fogelman I
Br J Rheumatol; 1992 Feb; 31(2):97-101. PubMed ID: 1371084
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
Frijlink WB; Bijvoet OL; te Velde J; Heynen G
Lancet; 1979 Apr; 1(8120):799-803. PubMed ID: 86042
[TBL] [Abstract][Full Text] [Related]
39. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
Patel S; Coupland CA; Stone MD; Hosking DJ
Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Dewis P; Prasad BK; Anderson DC; Willets S
Ann Rheum Dis; 1985 Jan; 44(1):34-8. PubMed ID: 3918513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
